Published in Virology on December 01, 1958
Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics. Proc Natl Acad Sci U S A (1962) 5.15
The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant. Mol Cell Biol (1988) 3.24
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src. Mol Cell Biol (1990) 2.39
Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev (1996) 2.14
Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J Virol (1972) 2.01
Murine sarcoma virus transformation of BALB-3T3 cells: lack of dependence on murine leukemia virus. Proc Natl Acad Sci U S A (1970) 1.96
Distinguishable transformation-defective phenotypes among temperature-sensitive mutants of Rous sarcoma virus. J Virol (1977) 1.79
RESPONSE OF CULTURED RABBIT CELLS TO INFECTION WITH THE SHOPE FIBROMA VIRUS. I. PROLIFERATION AND MORPHOLOGICAL ALTERATION OF THE INFECTED CELLS. J Bacteriol (1964) 1.69
Generation of transforming viruses in cultures of chicken fibroblasts infected with an avian leukosis virus. J Virol (1981) 1.68
Cellular tumorigenicity in nude mice. Test of associations among loss of cell-surface fibronectin, anchorage independence, and tumor-forming ability. J Cell Biol (1979) 1.63
Differential effects of transforming avian RNA tumor viruses on avian macrophages. Proc Natl Acad Sci U S A (1981) 1.60
p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J Cell Biol (1998) 1.59
Dynamic regulation of the structure and functions of integrin adhesions. Dev Cell (2013) 1.57
The susceptibility of differentiating muscle clones to Rous sarcoma virus. Proc Natl Acad Sci U S A (1966) 1.55
Viruses associated with human cancer. Biochim Biophys Acta (2007) 1.47
Transformation by murine sarcoma virus: fixation (deoxyribonucleic acid synthesis) and development. J Virol (1968) 1.28
Two loci controlling genetic cellular resistance to avian leukosis-sarcoma viruses. J Virol (1967) 1.27
In vitro chick embryo cell response to strain MC29 avian leukosis virus. J Virol (1968) 1.26
100 years of Rous sarcoma virus. J Exp Med (2011) 1.24
Immunofluorescent studies of group-specific antigen of the avian sarcoma-leukosis viruses. Proc Natl Acad Sci U S A (1966) 1.24
Cell-associated nature of cottontail rabbit herpesvirus in vitro. Appl Microbiol (1970) 1.17
Locomotory behavior, contact inhibition and pattern formation of 3T3 and polyoma virus-transformed 3T3 cells in culture. J Cell Biol (1977) 1.15
The history of tumor virology. Cancer Res (2008) 1.14
Retroviral oncogenes: a historical primer. Nat Rev Cancer (2012) 1.10
Insertional oncogenesis by non-acute retroviruses: implications for gene therapy. Viruses (2011) 1.09
Cellular immunity against Rous sarcomas of chickens. Preferential reactivity against autochthonous target cells as determined by lymphocyte adherence and cytotoxicity tests in vitro. Proc Natl Acad Sci U S A (1974) 1.08
Sequence of events in the transformation process in cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1981) 1.05
FURTHER STUDIES ON SPECIFIC TRANSPLANTATION ANTIGENS IN ROUS SARCOMA OF MICE. J Exp Med (1965) 1.04
Replication-defective ecotropic murine leukemia viruses: Detection and quantitation of infectivity using helper-dependent XC plaque formation. J Virol (1978) 1.03
Viruses and the neuroglia with special reference to scrapie, kuru and disseminated sclerosis. Proc R Soc Med (1967) 0.99
Use of immobilized lactoperoxidase to label L cell proteins involved in adhesion to polystyrene. J Cell Biol (1980) 0.98
COMPARATIVE STUDIES IN ROUS SARCOMA WITH VIRUS, TUMOR CELLS, AND CHICK EMBRYO CELLS TRANSFORMED IN VITRO BY VIRUS : I. PRODUCTION OF MUCOPOLYSACCHARIDES. J Exp Med (1961) 0.94
Transformation of chicken embryo fibroblasts by v-src uncouples beta1 integrin-mediated outside-in but not inside-out signaling. Mol Cell Biol (2001) 0.93
Non-specific inhibition by virus particles of human lymphocytes mitogenesis. Clin Exp Immunol (1980) 0.93
Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype. Proc Natl Acad Sci U S A (2008) 0.92
On the concept and elucidation of endogenous retroviruses. Philos Trans R Soc Lond B Biol Sci (2013) 0.91
Response of cell and organism to infection with avian tumor viruses. Bacteriol Rev (1962) 0.90
Detection and assay of avian tumor virus group-specific antigen and antibody by the paired radioiodine-labeled antibody technique. J Virol (1972) 0.90
The early history of tumor virology: Rous, RIF, and RAV. Proc Natl Acad Sci U S A (2011) 0.90
Non-specific effects of avian retrovirus co-incubation on lymphocyte function: abrogation of antigen- and mitogen-induced proliferative responsiveness. Immunology (1979) 0.89
Occurrence of focal three-dimensional proliferation in cultured human cells after prolonged infection with herpes simplex virus. J Exp Med (1961) 0.88
The effects of T-cell growth factor and virus purification on virus-mediated inhibition of lymphocyte mitogenesis. Clin Exp Immunol (1982) 0.87
Murine leukemia viruses: objects and organisms. Adv Virol (2011) 0.87
Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic. Int J Cancer (2010) 0.84
Neoplastic transformation by polyoma virus and its wider implications. Br Med J (1963) 0.84
Evidence for a DNA replicative genome for RNA-containing tumor viruses. Proc Natl Acad Sci U S A (1970) 0.84
Viruslike particles in nuclei of cultured plant cells which have lost the ability to differentiate. Proc Natl Acad Sci U S A (1970) 0.83
In vitro and in vivo observations on a murine C-type virus. J Virol (1967) 0.83
Comparative studies in Rous sarcoma with virus, tumor cells, and chick embryo cells transformed in vitro by virus. II. Response of normal and immunized chicks. J Exp Med (1962) 0.83
Genetics of resistance of fowl to infection by RNA tumour viruses. Proc R Soc Med (1976) 0.83
Expression of a molecularly cloned human c-src oncogene by using a replication-competent retroviral vector. Mol Cell Biol (1986) 0.82
Mechanism of oncogenic transformation by Rous sarcoma virus. II. Effect of rifampin on Rous sarcoma virus infection. J Virol (1971) 0.80
Reversible interference with TCGF activity by virus particles. Clin Exp Immunol (1984) 0.80
Scientific discovery and scientific reputation: the reception of Peyton Rous' discovery of the chicken sarcoma virus. J Hist Biol (2010) 0.79
Division of BALB/c mouse 3T3 and simian virus 40-transformed 3T3 cells in cellular aggregates. Proc Natl Acad Sci U S A (1977) 0.79
Viral abrogation of lymphocyte mitogenesis: induction of a soluble factor inhibitory to cellular proliferation. Immunology (1980) 0.78
Peyton Rous: father of the tumor virus. J Exp Med (2005) 0.78
Oncometabolites: Unconventional triggers of oncogenic signalling cascades. Free Radic Biol Med (2016) 0.78
The role of oncogenes in gastrointestinal cancer. Gastrointest Cancer Res (2010) 0.78
No activation of new initiation points for deoxyribonucleic acid replication in BALB/c 3T3 cells transformed by Kirsten sarcoma virus. Mol Cell Biol (1981) 0.78
Promotion and selection by serum growth factors drive field cancerization, which is anticipated in vivo by type 2 diabetes and obesity. Proc Natl Acad Sci U S A (2013) 0.78
Delineation of functional determinants in the transforming protein of Fujinami sarcoma virus. J Virol (1990) 0.78
Enhancement of avian sarcoma virus-induced tumor growth after pretreatment with BCG. Infect Immun (1978) 0.77
Discovery of oncogenes: The advent of molecular cancer research. Proc Natl Acad Sci U S A (2015) 0.77
Retroviral Integrase: Then and Now. Annu Rev Virol (2015) 0.77
Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy. Viruses (2014) 0.77
Not beyond reasonable doubt: Howard Temin's provirus hypothesis revisited. J Hist Biol (2010) 0.76
Oncogenes and the revolution in cancer research: homage to hidesaburo hanafusa (1929-2009). Genes Cancer (2010) 0.76
Cellular adaptation to biomechanical stress across length scales in tissue homeostasis and disease. Semin Cell Dev Biol (2016) 0.76
Medulloblastoma-biology and microenvironment: a review. Pediatr Hematol Oncol (2012) 0.76
Role of mitochondria in the production of RNA-containing tumor viruses. J Virol (1973) 0.75
Improved techniques for staining and enumerating focus formation in viral infectivity assays. Appl Microbiol (1974) 0.75
Effect of prior inoculation with chemical carcinogens on development of avian retrovirus-induced neoplasia in chickens. Br J Cancer (1980) 0.75
Physical, chemical and biological characteristics of two bovine enterovirus plaque variants. Can J Comp Med (1972) 0.75
COMPARATIVE STUDIES IN ROUS SARCOMA WITH VIRUS, TUMOR CELLS AND CHICK EMBRYO CELLS TRANSFORMED IN VITRO BY VIRUS : III. MALIGNANCY IN VIVO OF CELLS TRANSFORMED IN VITRO BY VIRUS. J Exp Med (1962) 0.75
Enhanced viral inhibition of lymphocyte mitogenesis in patients with advanced breast cancer. Clin Exp Immunol (1985) 0.75
Transduction of proto-src sequences in tissue culture by a molecular clone of transformation-defective Rous sarcoma virus with an internal src deletion. J Virol (1988) 0.75
Tumor viruses. Yale J Biol Med (1965) 0.75
Cancer: we should not forget the past. J Cancer (2015) 0.75
Virus production and release, cell longevity, and cloning efficiency of chicken embryo fibroblasts infected with Rous sarcoma virus. Infect Immun (1974) 0.75
Some systems for the genetic analysis of mammalian cells. Am J Hum Genet (1960) 0.75
Cell-virus Interactions with the Polyoma Virus: The Induction of Cell Transformation and Malignancy in vitro. Br J Cancer (1961) 0.75
Immunological responsiveness against tumors induced by avian sarcoma virus: reduced expression of pp60src kinase activity in regressing tumors. J Virol (1985) 0.75
A LEUKAEMIA VIRUS--PASSENGER OR DRIVER? Br Med J (1964) 0.75
The defectiveness of Rous sarcoma virus. Proc Natl Acad Sci U S A (1963) 6.40
An analysis of the assay of Rous sarcoma cells in vitro by the infective center technique. Virology (1960) 4.83
An avian leukosis virus associated with stocks of Rous sarcoma virus. Virology (1962) 4.27
ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS, II. SPECIFICATION OF RSV ANTIGENICITY BY HELPER VIRUS. Proc Natl Acad Sci U S A (1964) 3.77
A radiological study of cell-virus interaction in the Rous sarcoma. Virology (1959) 3.24
A kinetic study of infection of chick embryo cells in vitro by Rous sarcoma virus. Virology (1959) 3.07
THE PARTICIPATION OF DNA IN ROUS SARCOMA VIRUS PRODUCTION. Virology (1964) 2.70
THE EFFECTS OF ACTINOMYCIN D ON GROWTH OF ROUS SARCOMA VIRUS IN VITRO. Virology (1963) 2.68
The control of cellular morphology in embryonic cells infected with rous sarcoma virus in vitro. Virology (1960) 2.39
ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS. I. CHARACTERIZATION OF THE HELPER VIRUS. Virology (1964) 2.35
The maturation of Western equine encephalomyelitis virus and its release from chick embryo cells in suspension. J Exp Med (1955) 2.22
HOMOLOGY BETWEEN RNA FROM ROUS SARCOMA VIROUS AND DNA FROM ROUS SARCOMA VIRUS-INFECTED CELLS. Proc Natl Acad Sci U S A (1964) 2.19
Interactions between Newcastle disease virus (NDV), antibody and cell. Virology (1957) 2.12
Separation of morphological conversion and virus production in Rous sarcoma virus infection. Cold Spring Harb Symp Quant Biol (1962) 1.96
Localization of infectious virus and viral antigen in chick fibroblasts during successive stages of infection with Rous sarcoma virus. Virology (1961) 1.81
Antibody elution from red blood cells. J Clin Pathol (1963) 1.75
Quantitative relations between causative virus and cell in the Rous no. 1 chicken sarcoma. Virology (1955) 1.74
Tolerance and immunity in chickens after congenital and contact infection with an avian leukosis virus. Virology (1962) 1.66
GENETIC CONTROL OF CELLULAR SUSCEPTIBILITY TO PSEUDOTYPES OF ROUS SARCOMA VIRUS. Virology (1965) 1.63
The pattern of congenital transmission of an avian lekosis virus. Proc Natl Acad Sci U S A (1961) 1.61
Epidemic infection with Coxsackie virus group B, type 5. I. Clinical and epidemiologic aspects. N Engl J Med (1958) 1.57
On the mechanism of Newcastle disease virus neutralization by immune serum. Virology (1957) 1.57
The suppression of morphological alterations in cells infected with Rous sarcoma virus. Virology (1960) 1.46
Infection of chick iris epithelium with the Rous sarcoma virus in vitro. Virology (1960) 1.42
Studies on the assay and multiplication of avian myeloblastosis virus. Virology (1963) 1.40
Mixed infection with two types of Rous sarcoma virus. Virology (1961) 1.39
Infection and growth of Newcastle disease virus (NDV) in cultures of chick embryo lung epithelium. Virology (1957) 1.33
The immunological basis for non-infective Rous sarcomas. Cold Spring Harb Symp Quant Biol (1962) 1.32
The course and prognosis of histoplasmosis. Am J Med (1959) 1.26
Infection with the Rous sarcoma virus in vitro. Fed Proc (1958) 1.16
The treatment of cryptococcal meningitis with amphotericin B, a new fungicidal agent. Ann Intern Med (1958) 1.14
Isolation of a psittacosis-like agent from the blood of snowy egrets. Proc Soc Exp Biol Med (1951) 1.08
Epidemic infection with Coxsackie virus, group B, type 5. 2. Virus excretion and neutralizing antibody response. Am J Hyg (1958) 1.07
The nature of a virus-induced cellular resistance to Rous sarcoma virus. Virology (1961) 1.07
The production, purification, and properties of Newcastle disease virus labeled with radiophosphorus. Virology (1957) 1.03
Recovery of virus of Eastern equine encephalomyelitis from a mosquito, Culiseta melanura (Coquillett). Proc Soc Exp Biol Med (1951) 1.02
The production of virus by Rous sarcoma cells. Ann N Y Acad Sci (1957) 0.95
The cytology of Rous sarcoma virus infection. Cold Spring Harb Symp Quant Biol (1962) 0.92
Promising results in cryptococcal meningitis. Neurology (1958) 0.92
Conditions for establishing immuno logical tolerance to a tumor virus. Nature (1962) 0.90
Response of cell and organism to infection with avian tumor viruses. Bacteriol Rev (1962) 0.90
Influence of tumor virus infection on the antigenicity and behavior of cells. Cancer Res (1961) 0.89
THE DUAL ORIGIN OF NONINFECTIVE ROUS SARCOMAS. J Natl Cancer Inst (1964) 0.88
TRUE RED BLOOD CELL SURVIVAL WITH RADIOCHROMIUM BY CORRECTING FOR PERCENTAGE OF ACTIVITY NOT BOUND TO HEMOGLOBIN. DEMONSTRATION OF TWO ERYTHROCYTE POPULATIONS IN NORMALS AND IN THALASSEMIA MINOR. ERYTHROPOIESIS AND THE THALASSEMIA TRAIT. Ann N Y Acad Sci (1964) 0.86
MALIGNANT TRANSFORMATION IN CELL CULTURES. Health Lab Sci (1964) 0.85
Growth of Rous sarcoma virus in chick embryo cells following irradiation of host cells or free virus. Virology (1960) 0.84
Further evidence for a converted, non-virus-producing state of Rous sarcoma virus-infected cells. Virology (1963) 0.83
A disease in captive egrets caused by a virus of the psittacosis-lymphogranuloma venereum group. J Infect Dis (1954) 0.83
Severe nonfatal histoplasmosis; report of a typical case, with comments on therapy. N Engl J Med (1957) 0.82
VIRUS DEFECTIVENESS AND CELL TRANSFORMATION IN THE ROUS SARCOMA. J Cell Physiol (1964) 0.82
CARCINOGENIC INTERACTIONS BETWEEN VIRUS, CELL, AND ORGANISM. JAMA (1964) 0.81
Effect of central depression on survival following acute coronary occlusion. Surg Forum (1958) 0.80
An analysis of the apparent neutralization of Rous sarcoma virus with antiserum to normal chick tissues. Virology (1956) 0.80
Pathology of eastern equine encephalomyelitis. Am J Vet Res (1951) 0.77
SYSTEMIC CYSTIC ANGIOMATOSIS. Am J Med (1964) 0.77
Immunological relationships between virus and cell in the Rous sarcoma. Ann N Y Acad Sci (1957) 0.76
Epidemiological studies of aseptic meningitis caused by Coxsackie virus B5. Am J Public Health Nations Health (1958) 0.75
Recovery of virus of Eastern equine encephalomyelitis from blood of a purple grackle. Proc Soc Exp Biol Med (1951) 0.75
A cross-validation of suggested Rorschach patterns associated with schizophrenia. J Consult Psychol (1953) 0.75
Cesarean section. Trans N Engl Obstet Gynecol Soc (1956) 0.75
[The problem of otitis externa]. Harefuah (1958) 0.75
[Studies on the influence of atropine on enzyme formation in the pancreas]. Z Gesamte Exp Med (1963) 0.75
[Acute thyroiditis in three persons of the same family]. Harefuah (1946) 0.75
WURSTER COATED ASPIRIN. I. FILM-COATING TECHNIQUES. J Pharm Sci (1964) 0.75
The Taylor manifest anxiety scale in differential diagnosis. J Clin Psychol (1958) 0.75
A DEFECTIVE CANCER VIRUS. Sci Am (1964) 0.75
A note on "Reply to Rubin.". J Consult Psychol (1950) 0.75
Validity of a critical-item scale for schizophrenia on the MMPI. J Consult Psychol (1954) 0.75
USE OF CHROMIUM51-TAGGED CASEIN FOR THE DETERMINATION OF PROTEOLYTIC ACTIVITY. J Lab Clin Med (1964) 0.75
Amphotericin B in the treatment of cryptococcal meningitis. Antibiot Annu (1958) 0.75
DIFFERENTIAL RESPONSIVENESS OF ROUS SARCOMA VIRUS STOCKS TO SPECIFIC CELLULAR RESISTANCE INDUCED BY AVIAN LEUKOSIS VIRUSES. Virology (1964) 0.75
Disposable enema unit in obstetrics. Obstet Gynecol (1958) 0.75
Carotid grafts. Acta Unio Int Contra Cancrum (1960) 0.75
A quantitative study of the HTP and its relationship to the Wechsler-Bellevue scale. J Clin Psychol (1954) 0.75
Manifest anxiety in psychotics. J Clin Psychol (1956) 0.75
Carotid grafts. Plast Reconstr Surg Transplant Bull (1960) 0.75
The Minnesota multiphasic personality inventory as a diagnostic aid in a Veterans Hospital. J Consult Psychol (1948) 0.75